US2017181967A1PendingUtilityA1

Methods and compositions for applying pharmacologic agents to the ear

Assignee: UNIV MINNESOTAPriority: Nov 27, 2002Filed: Mar 13, 2017Published: Jun 29, 2017
Est. expiryNov 27, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61P 29/00A61P 31/04A61P 27/16A61P 31/00A61P 31/12A61P 31/10A61K 9/0046A61K 31/7048A61K 31/43A61K 9/06A61K 31/545A61K 31/5386A61K 31/716A61K 31/4402A61K 31/5415A61K 31/546A61P 23/02A61K 47/34
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and materials useful for applying pharmacologic agents to the ear are described. The methods involve delivering a composition that contains at least one viscogenic agent and at least one pharmacologic agent to the epidermal surface of the tympanic membrane via the ear canal. The composition is delivered to the tympanic membrane in a flowable form and, after delivery to the tympanic membrane, becomes sufficiently viscous such that the pharmacologic agent is localized against the tympanic membrane. Such compositions can be used to prophylactically and/or therapeutically treat middle and inner ear conditions, including otitis media.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A kit comprising a formulation and instructions indicating that said formulation is to be applied to a tympanic membrane, wherein said formulation is aqueous and comprises a viscogenic agent and at least one pharmacologic agent, wherein said formulation is flowable and has a viscosity less than 100,000 cps, and wherein said formulation, after application to said tympanic membrane, forms a gel that has a yield stress sufficient to maintain said formulation against said tympanic membrane, wherein said formulation allows for transfer of the pharmacologic agent across the tympanic membrane and into the middle ear space.

Join the waitlist — get patent alerts

Track US2017181967A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.